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A B S T R A C T  
Objective: To determine the prevalence of Y chromosome microdeletions in Pakistani idiopathic infertile men, using 
multiplex polymerase chain reaction.  
Patients and Methods: A case control study was conducted on the infertile male patients attending OPD’s of Aziz 
Medical Hospital and National Center for Fertility Control, Jinnah Post Graduate Medical Center (JPMC), Karachi. A total 
of 220 primary infertile men, of which 150 (68.2%) had azoospermia, 40 (18.2%) had severe oligozoospermia and 30 
(13.6%) had oligozoospermia and 220 fertile men as control group were studied. Six sequence-tagged sites: sY84 and 
sY86 for AZFa, sY127 and sY134 for AZFb, and sY254 and sY255 for AZFc were used for amplification of the 
azoospermia factor region of Y chromosome according to the recommendations of European Academy of Andrology and 
the European Quality Monitoring Network Group.  
Results: Yq microdeletions were found in (12) 5.45% cases, while none in the control group (p =<0.007). All the 
microdeletions were found in azoospermics 12/150 (8.0%). Among patients with microdeletions, the AZFa region was 
found to be deleted in 1 (8.33%), AZFb in 2 (16.67%), AZFc in 6 (50%), AZFb+c in 2 (16.67%) and complete AZF 
deletions in 1 (8.33%) patients. Identification of Y chromosome microdeletions in Pakistani infertile males was found to 
have significant diagnostic and prognostic value and provides useful information for genetic counseling in patients 
choosing assisted reproductive treatments. 
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chromosome microdeletions. 
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I n t r o d u c t i o n  
 
Approximately 10–15% of couples are affected by 
infertility which come into consideration when the couples 
fail to conceive after unprotected coitus for more than one 
year. A male factor can be diagnosed in approximately 
50% of them. The main causes of this disorder for men 
are associated with various factors, among them are 
genetic, physio-pathologic and anatomo-pathologic 
abnormalities, intense and prolonged physical exercises, 
aging, drugs, and even excessive time of sexual 
abstinence.1 In almost 20% of cases in which male 
infertility cannot be attributed to any other cause, the role 
of genetic alterations is being increasingly scrutinized.2 
This form of infertility can be classified as a genetic 
disorder, where structural chromosomal alterations, 
ORIGINAL ARTICLE 
                           15 JIM DC  2017  15 
acquired or congenital, have been one of the main 
etiologic factors.3 Little is known about the reproductive 
genetic disorders that cause disruption of 
spermatogenesis. Early cytogenetic studies showed that 
microscopic deletions in the long arm of Y chromosome 
are responsible for azoospermia and structural alterations 
in the Y chromosome have been the principal reason for 
male infertility.4  
Numerous investigations have documented interstitial 
microdeletions in AZFc region in both azoospermics and 
mild oligospermics. Such microdeletions have been 
reported with varied prevalence in different populations. 
For example, the studies in Brazilian population reported 
both low (6.7%)  as well as high (44%) prevalence of Yq 
microdeletions in the AZFc region in infertile males.5,6 
Likewise, low frequency (5.1%) as well high frequency 
(17.4%) has been shown in Chinese population.7,8 Further 
the range of frequency of AZFc region deletion in Indian 
population has been 5.3% -15%.9,10  AZFc deletions and 
partial AZFb deletions are associated with sperm retrieval 
in 50% of cases, while in cases of AZFb deletions, 
probability of finding sperm is virtually nil. However, 
retrieved sperms are found to be fully fertile in both Intra-
cytoplasmic Sperm Injection (ICSI) and In vitro fertilization 
(IVF) procedures. ICSI allows partners of infertile men to 
become pregnant; however, it is possible that Y deletions 
may be transmitted to the male offspring. Substantial 
prevalence of Y deletions in infertile men and the potential 
risk of transmitting this genetic disorder to their offspring 
provide a compelling rationale for screening of infertile 
men prior to ICSI.11 
The status of AZFc in the genetic involvement of male 
infertility has been documented in many countries with 
varying frequency. So far only two studies have reported 
Y chromosome microdeletions in Pakistani infertile men. 
One of these studies was conducted in Lahore and has 
not reported any microdeletions, whereas another study 
which was conducted in Islamabad reported an overall 
prevalence of 11.6% Yq microdeletions in Pakistani 
infertile men.12,13 Thus, it becomes imperative to 
investigate the deletions of AZFc region localization in 
Pakistani population. The aim of this study was to detect 
genetic defect in male infertile patients attending infertility 
clinics and to evaluate it for etiological diagnosis in cases 
of idiopathic male infertility. 
    P a t i e n t s  a n d  M e t h o d s  
A case control study was conducted on the infertile male 
patients attending OPD’s of Aziz Medical Hospital and 
National Center for Fertility Control, Jinnah Post Graduate 
Medical Center (JPMC), Karachi. The bench work was 
carried out at Khan Institute of Biotechnology and Genetic 
Engineering (KIBGE), University of Karachi from June 
2012 to May 2013. A purposive non probability sample of 
220 idiopathic infertile men with a normal karyotype aged 
between 21 and 60 years (mean ± SD = 33.54 ± 6.57) 
were screened for the presence of Y chromosome 
microdeletions. Two hundred and twenty age-matched 
(mean ± SD = 37.24 ± 5.65 years) fertile men with proven 
fertility and sperm count > 20 million/ml were considered 
as control group; also a female sample was used as 
negative control. Informed written consent was obtained 
from each and every subject included in the study and 
confidentiality and anonymity of the data was ensured. 
The study was approved by the Institutional Review Board 
(IRB) of Dow University of Health Sciences (DUHS).   
A detailed history and physical examination was done on 
all the subjects. Semen analysis was performed according 
to normal standard parameters using the World Health 
Organization (WHO) criteria. Infertile men (n=220) were 
divided into 3 groups on the basis of sperm count: 
azoospermic (No spermatozoa), severe oligozoospermic 
(less than 5 million/ ml) and oligozoospermic (less than 20 
million/ml). Five microlitre of venous blood was also 
collected in a tube containing Ethylene Diamine 
Tetraacetate (EDTA) as an anticoagulant for DNA 
extraction. Genomic DNA was extracted utilizing Phenol 
chloroform method. Polymerase Chain Reaction (PCR) 
was performed according to the standard protocol for 
analysis of the AZF region of the Y-chromosome. Three 
sub-regions were analyzed: AZFa, AZFb and AZFc, 
where sequence tagged site (STS) markers were used. 
As positive control, fertile men with naturally conceived 
children were used. These STS markers were suggested 
by the European Academy of Andrology which are able to 
detect 90% of the deletions in the loci of AZF.2 
The PCR amplification reaction mix comprised a total 
volume of 15μL, which contained 1.5μg of 50ng/μL human 
genomic DNA as template, 1 μL of 2mM dNTP’s 
(Fermentas), 5μL of 100 μM each of the forward and 
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reverse primers (Pennicon), 0.3μL of 50mM MgCl2 
(Geneaid) and 0.1μL of 5 units/μL Taq DNA polymerase 
(Geneaid), 1.5μL of 10X PCR Buffer (Geneaid) and 0.6μL 
of deiodinized water. The conditions for thermocycling 
were standardized for the sub-regions, utilizing a Thermo 
Hybaid MBS 0.2S PCR Thermal Cycler.  
Two sets of Multiplex PCR were used; Multiplex A (sY86, 
sY127, sY254) and Multiplex B (sY84, sY134, sY255). In 
addition, two sets of primers (ZFX/ZFY and sY14) were 
used to amplify SRY and ZFY regions as internal controls 
as shown in Table 1. The cycling conditions for multiplex 
A PCR amplifications were: 35 cycles at 95ºC 78 ºC and 
52 ̊ºC for 45 seconds each. Initial denaturation was done 
at 94 ºC for 4 min and final extension at 72 ºC for 10 min. 
The cycling conditions for multiplex B PCR amplifications 
were: 35 cycles at 95̊C, 78 ºC and 52ºC for 45 seconds 
each in cycle. Initial denaturation was done at 94ºC for 4 
min and final extension at 72ºC for 10 min in both the 
multiplex. The amplified PCR product (15uL) was loaded 
in 2% agarose gel in 1x Tris-Borate EDTA (TE) Buffer and 
was run by gel electrophoresis in gel assembly for 30 
minutes at 200 volts. The gel was stained with ethidium 
bromide (5ug/100ml) and the results were visualized by 
gel documentation system under UV light and 
photographed. The size of the DNA bands was identified 
by comparing with the molecular weight marker (100bp 
DNA ladder) (Fermentas, 0.5μg/μL) loaded in a separate 
lane. This analysis was performed at least three times on 
samples with microdeletions. In each multiplex PCR 
essay, one sample from healthy female was used as 
negative control, and healthy fertile male was used as 
positive control. Statistical analysis was carried out by the 
Statistical Package for Social Science version 16.0. The 
student’s t test and Chi-square were used to determine 
the associations among the different parameters. P value 
of less than 0.05 was considered to be significant. 
R e s u l t s  
 Among total of 220 subjects of the study group, mean 
age of the patients was found to be 33.54 ±6.57 years 
whereas it was 37.24 years ± 5.65SD for the control 
group. The mean age of their wives was 28.15 years ± 
4.63SD, whereas mean age in control group was 27.99 
years ± 5.05 SD. The average time since the marriage in 
                     Table 1. Sequence-tagged Sites (STS) used in the detection of Y chromosomal microdeletions 
Multiplex STS Locus Region Sequence 5’ to 3’ Bp 
 
 
  
  
A and B 
ZFX/ZFY ZFX/ZFY Xq34 
 
495 
 
 Yp22.3 
  
 
 
  
  
A and B 
sY14 SRY Yp11.3 
 
472 
 
  
  
 
 
  
  
A 
sY254 DAZ AZFc  F 5′-GGG TGT TAC CAG AAG GCA AA-3′ 380 
 
   R 5′-GAA CCG TAT CTA CCA AAG CAG C-3′ 
 
 
 
  
  
A 
sY86 DYS148 AZFa 
 
318 
 
  
  
 
 
  
  
A 
sY127 DYS218 AZFb   F 5′-GGC TCA CAA ACG AAA AGA AA-3′ 274 
 
    R 5′-CTG CAG GCA GTA ATA AGG GA-3′ 
 
 
 
  
  
B 
sY84 DYS273 AZFa   F 5′-AGA AGG GTC CTG AAA GCA GGT-3′ 326 
 
    R 5′-GCC TAC TAC CTG GAG GCT TC-3′ 
 
 
 
  
  
B 
sY134 DYS224 AZFb 
 
301 
 
  
  
 
 
  
  
B 
sY255 DAZ AZFc 
 
123 
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study group was 6.98 years ± 4.85 SD and was 5.39 
years ± 5.26 SD in control group (Table 2). The semen of 
the enrolled patients was analyzed for the number of 
sperms as per WHO criteria as shown in Figure 1. 
 
Figure 1. Distribution of the infertile men and healthy fertile 
controls on the basis of Sperm Counts (million/ml) 
Amongst the total of 220 subjects (shown in Red) that 
were included in the study, 68.2% males (n=150) were 
found to be azoospermic i.e. having no sperm in their 
semen. About 18.2% cases (n=40) were found to be 
severely oligospermic i.e. having sperm count less than 5 
million/ml, while 13.6% patients (n=30) were found to be 
oligospermic having sperm count less than 20 million/ml. 
Amongst the control group (shown in blue), 99.1% 
(n=218) individuals had their sperm count greater than 20 
million/ml while only 0.9% (n=2) were found oligospermic. 
The sperm counts for the two groups had significant 
difference with p value of <0.01. Table 3 shows that the 
microdeletions in the Y-chromosome were found in 5.45% 
cases (12 individuals out of 220) while no microdeletion 
was detected in controls. (p =<0.007). Amongst the 
microdeletions that were reported during the study, 2.73% 
were isolated AZFc deletions; 0.91% were AZF b and 
AZFb+c deletions each while 0.45% deletions were found 
in AZFa and AZFabc regions. These microdeletions were 
observed in azoospermics only.  Of all the microdeletions, 
the AZFa region was found to be deleted in 8.33% (1/12), 
AZFb in 16.67% (2/12), AZFc in 50% (6/12), AZFb+c in 
16.67% (2/12) and AZFa+b+c in 8.33% (1/12) patients. 
Figure 2 represents optimization of the primers of 
Multiplex PCR: 100 bp, Ladder; 1, Primer 1 (495 bp); 2, 
Primer 2 (475 bp); 3, Primer 3 (320 bp); 4, Primer 4 (274 
bp); 5, Primer 5 (380 bp); 6, Primer 6 (326 bp); 7, Primer 
7 (301 bp); 8, Primer 8 (123 bp). Figure 3 shows the 
absence of band of 380 bp in lane 5, 6 and 7 which 
corresponds to AZFc region. Band of 274 bp and 380 bp 
are absent in lane 8 and 9 showing deletion in the AZFb + 
c region whereas lane 10 shows complete deletion of the 
entire AZF region. Figure 4 shows the absence of band of 
123 bp in lane 5, 6 and 7 which corresponds to AZFc 
region. Band of 301 bp and 12 bp are absent in lane 8 
and 9 showing deletion in the AZFb + c region whereas 
lane 10 shows complete deletion of the entire AZF region 
Table 2: Age of the couples and duration of marriage 
Parameter Cases (n=220) Control (n=220) 
 Mean ± SD 
95% CI 
(Lower – Upper) 
Mean ± SD 
95% CI 
(Lower – Upper) 
Age of the patients (years) 33.54 ± 6.57 32.67 – 34.41 37.24 ± 5.65 36.49 – 37.99 
Age of the wife (years) 28.15 ± 4.63 27.53 – 28.76 27.99 ± 5.05 27.32 – 28.66 
Years since married 6.98 ± 4.85 6.34 – 7.63 5.39 ± 5.26 4.69 – 6.09 
Table 3. Deletion rate and Distribution of observed microdeletions of AZF region on Y chromosome in infertile men   
AZF region 
Azoospermia 
(n=150) 
Severe Oligozoospermia 
(n=40) 
Oligozoospermia 
(n=30) 
Total 
(n=220) 
Deletion rate 
(%) 
AZFa 1 - - 1 0.45 
AZFb 2 - - 2 0.91 
AZFc 6 - - 6 2.73 
AZF b+c 2 - - 2 0.91 
AZF a+b+c 1 - - 1 0.45 
Total (%) 12 (8%) - - 12 5.45 
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Figure 2: Optimized Multiplex PCR with all the eight 
primers 
 
Figure 3: Multiplex A: lane 1, 100bp DNA Ladder; lane 2, 
DNA of normal fertile male as +ve Control; lane 3, female 
DNA; lane 4, water as –ve Control; lane (5, 6, 7), DNA of 
AZFc deleted patient; lane (8, 9), DNA of AZFb+c deleted 
patient; lane 10, DNA of AZFa, b, c deleted patient. 
 
Figure 4: Multiplex B: lane 1, 100bp DNA Ladder; lane 2, 
DNA of normal fertile male as +ve Control; lane 3, female 
DNA; lane 4, water as –ve Control; lane (5, 6, 7), DNA of 
AZFc deleted patient; lane (8, 9), DNA of AZFb+c deleted 
patient; lane 10, DNA of AZFa, b, c deleted patient. 
D i s c u s s i o n  
Among numerous etiologic factors, genetics play a key 
role in male infertility with abnormal semen parameters.14-
16 Spermatogenesis is regulated by a number of genes on 
the Y chromosome and by autosomes that act at different 
stages of germ cell development.16 Previous reports have 
revealed that Y chromosome microdeletions vary from 1 
to 55% among infertile men all over the world, but most 
studies have reported an incidence below 15%.2 In the 
present study, the estimated frequency was 8% among 
azoospermic patients and an overall prevalence of 5.45% 
which is well within the range of the published data. No 
microdeletion was reported in a study conducted in 
Lahore city in 53 idiopathic azoospermic infertile men 
while using European Academy of Andrology (EAA) 
recommended STS markers.12 Another study conducted 
in Islamabad city for Y chromosomal microdeletions in 
oligozoospermic and azoospermic men reported an 
overall prevalence of 11.8% in 51 patients.13 These 
deletions were found solely in non-obstructive 
azoospermic patients which is also the case in our study 
as no microdeletion was found in the oligozoospermic or 
severe oligozoospermic patients.  
Wide variations in deletion frequency that are reported in 
previous published works could be caused by geographic 
and ethnic differences, genetic background, and 
environmental influences, different patient selection 
criteria, study designs, sample size and partly by 
methodological aspects.17,18 However, there are studies 
that suggest that the major factor influencing deletion 
frequency was the composition of study population and 
ethnic or geographical differences apparently had no 
influence on it.19,20 They found that the highest deletion 
frequency was in the group defined as idiopathic 
azoospermic with the incidence of 17 percent and the 
incidence decreases progressively with the inclusion of 
less severe phenotypes.20 It seems that the discrepancy 
in reported deletion frequencies in Pakistani population 
could be explained by (i) differences in the sample size, 
and (ii) ethnic variations since our samples were collected 
from Karachi which is a metropolitan city and 
accommodates people from many different ethnic groups 
and races.  
1 2 3 4 5 6 7 8 9 10 
1 2 3 4 5 6 7 8 9 10 
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It has been reported that AZFc microdeletion constitutes a 
progressive and deteriorating effect on spermatogenesis 
leading to a steady and methodical decline in 
spermatogenesis and deterioration in sperm quality.21 But, 
a clinical study of azoospermic and oligospermic men, did 
not agree to this concept as they found that the AZFc 
deleted men had their baseline sperm production potential 
stable over time.22 It has been shown that chromosome Y 
microdeletions are much less frequent when sperm 
concentration is less than 2 million/ml.23,24 This may be 
one of the reasons for the failure to detect Y 
microdeletions in the non-azoospermic groups which is 
also observed in our study where complete AZF deletion 
and the deletions of AZFa, AZFb, AZFb+c and all the 
AZFc deletions were all found only in azoospermic male. 
Deletions in AZFc region are the most commonly reported 
deletions among AZF microdeletions and its complete 
deletion is one of the most frequent genetics causes of 
severe male infertility. In a study conducted on 247 Saudi 
men with idiopathic azoospermia or oligospermia, 3.2% 
had Y chromosome microdeletion, consisted of 6 in the 
AZFc, 1 in the AZFb, and 1 in both AZFa and AZFc.15 
AZFa contains single copies of DFFRY (USP9Y) and DBY 
(DDX3Y) genes. It is suggested that complete deletion of 
AZFa region may result in complete SCO syndrome and 
azoospermia.2,4,25,26 Identification of deletions in this 
region is very important since it is impossible to retrieve 
testicular sperm for ICSI.2,25 In our study, AZFa region 
was involved in a total of 8.33% (1/12) of the observed Y 
chromosome microdeletions using sY84 and sY86 
sequence tagged sites. Deletion in this region was 
observed in combination with complete deletions of AZF 
region in one patient (8.33%). This is slightly higher than 
the percentage of deletions reported in literature in AZFa 
region, which is 2 -5%.19,27 This higher percentage was 
also reported by the another study conducted in our 
country, in which one patient out of six with microdeletions 
showed AZFa deletion (16.67%).13 A study conducted in 
India reported 2% AZFa region deletion.28 
AZFb deletion was involved in 41.7 % of the total 
deletions of which AZFb alone was involved in 16.67 %. 
Selected STS markers for detecting deletions in AZFb 
region in the present study were located in the median 
and distal part of AZFb and in the most cases the deletion 
of sY127 and sY134 markers, indicated a complete 
deletion of the AZFb region which may cause SCO 
syndrome or spermatogenetic arrest resulting in 
azoospermia.2 Two patients showed complete deletion of 
AZFb whereas two patients showed partial deletion in 
AZFb region. RBMY genes, including RBM1 and RBM2, 
located in AZFb region, are specifically expressed in testis 
and germ cells. The gene encodes a RNA binding protein 
that localizes to the nucleus of all spermatogenic cell 
types.25,29 Since several copies of these genes are 
located in the AZFb region, it is not clear whether the loss 
of the RBMY genes in men may result in male infertility or 
not, therefore, the role of deletion in these genes is not 
clear in the process of spermatogenesis.30 Several reports 
have shown that complete deletions in AZFb region will 
have the same results as deletions in AZFa region for 
testicular sperm extraction (TESE).2,25 Patients with 
complete or partial AZFb deletion in our study also 
showed maturation arrest in their testis biopsy; therefore, 
attempts for retrieving sperm were not successful. 
C o n c l u s i o n  
Y chromosome microdeletions proved to be the second 
most common etiology among genetic causes of male 
infertility after Klinefelter’s syndrome. However, men with 
microdeletions will presumably transmit the deletion, as 
well as the related fertility problem, to their sons. It is, 
therefore, very important not only to routinely screen for 
Yq microdeletion but also to offer proper genetic 
counseling to the couples particularly those who wish to 
undergo assisted reproductive techniques. 
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